TP53 and non-small cell lung carcinoma: Among the six “hot spot” missense point mutations, R273 is one of the most frequently mutated (6.7%) residues in human cancers [12], particularly in the NSCLC (~5%) (IARC database, http://www-p53.iarc.fr).